5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline

C73H73F9N18O8S4 — CID 160558480

IUPAC5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline
SMILESCCS(=O)(=O)c1ccc(NCc2ccc(C(F)(F)F)nc2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccc(C(F)(F)F)nn2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccc(C3CC3)cn2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)cn2)c(-c2cn(C)cn2)c1
InChIInChI=1S/C20H22N4O2S.C19H19F3N4O2S.2C17H16F3N5O2S/c1-3-27(25,26)16-7-8-18(17(10-16)19-12-24(2)13-22-19)23-20-9-6-15(11-21-20)14-4-5-14;1-3-29(27,28)14-5-6-16(15(8-14)17-11-26(2)12-25-17)23-9-13-4-7-18(24-10-13)19(20,21)22;1-3-28(26,27)12-4-5-14(13(6-12)15-9-25(2)10-23-15)24-16-21-7-11(8-22-16)17(18,19)20;1-3-28(26,27)11-4-5-13(12(8-11)14-9-25(2)10-21-14)22-16-7-6-15(23-24-16)17(18,19)20/h6-14H,3-5H2,1-2H3,(H,21,23);4-8,10-12,23H,3,9H2,1-2H3;4-10H,3H2,1-2H3,(H,21,22,24);4-10H,3H2,1-2H3,(H,22,24)
InChIKeyQYZOXYIWIIIBCL-UHFFFAOYSA-N
MW1629.75 g/mol
LogP14.67
Rot. Bonds22

About 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline

5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline (PubChem CID 160558480) has the molecular formula C73H73F9N18O8S4 and a molecular weight of 1629.75 g/mol. Its IUPAC name is 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline.

Molecular Properties

Compound Name5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline
PubChem CID160558480
Molecular FormulaC73H73F9N18O8S4
Molecular Weight1629.75 g/mol
Exact Mass1628.46
IUPAC Name5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline
SMILESCCS(=O)(=O)c1ccc(NCc2ccc(C(F)(F)F)nc2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccc(C(F)(F)F)nn2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccc(C3CC3)cn2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)cn2)c(-c2cn(C)cn2)c1
InChIInChI=1S/C20H22N4O2S.C19H19F3N4O2S.2C17H16F3N5O2S/c1-3-27(25,26)16-7-8-18(17(10-16)19-12-24(2)13-22-19)23-20-9-6-15(11-21-20)14-4-5-14;1-3-29(27,28)14-5-6-16(15(8-14)17-11-26(2)12-25-17)23-9-13-4-7-18(24-10-13)19(20,21)22;1-3-28(26,27)12-4-5-14(13(6-12)15-9-25(2)10-23-15)24-16-21-7-11(8-22-16)17(18,19)20;1-3-28(26,27)11-4-5-13(12(8-11)14-9-25(2)10-21-14)22-16-7-6-15(23-24-16)17(18,19)20/h6-14H,3-5H2,1-2H3,(H,21,23);4-8,10-12,23H,3,9H2,1-2H3;4-10H,3H2,1-2H3,(H,21,22,24);4-10H,3H2,1-2H3,(H,22,24)
InChIKeyQYZOXYIWIIIBCL-UHFFFAOYSA-N
XLogP14.67
TPSA333.30 Ų
H-Bond Donors4
H-Bond Acceptors26
Rotatable Bonds22
Heavy Atoms112
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001629.75
LogP ≤ 514.67
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1026

Analyze 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline?
The IUPAC name of 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline (CID 160558480) is 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline.
What is the SMILES notation for 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline?
The canonical SMILES for 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline is CCS(=O)(=O)c1ccc(NCc2ccc(C(F)(F)F)nc2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccc(C(F)(F)F)nn2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ccc(C3CC3)cn2)c(-c2cn(C)cn2)c1.CCS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)cn2)c(-c2cn(C)cn2)c1.
What is the InChIKey of 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline?
The InChIKey is QYZOXYIWIIIBCL-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H22N4O2S.C19H19F3N4O2S.2C17H16F3N5O2S/c1-3-27(25,26)16-7-8-18(17(10-16)19-12-24(2)13-22-19)23-20-9-6-15(11-21-20)14-4-5-14;1-3-29(27,28)14-5-6-16(15(8-14)17-11-26(2)12-25-17)23-9-13-4-7-18(24-10-13)19(20,21)22;1-3-28(26,27)12-4-5-14(13(6-12)15-9-25(2)10-23-15)24-16-21-7-11(8-22-16)17(18,19)20;1-3-28(26,27)11-4-5-13(12(8-11)14-9-25(2)10-21-14)22-16-7-6-15(23-24-16)17(18,19)20/h6-14H,3-5H2,1-2H3,(H,21,23);4-8,10-12,23H,3,9H2,1-2H3;4-10H,3H2,1-2H3,(H,21,22,24);4-10H,3H2,1-2H3,(H,22,24).
What are the key properties of 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline?
5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline has a molecular weight of 1629.75 g/mol, XLogP of 14.67, 22 rotatable bonds, 4 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 5-cyclopropyl-N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]pyridin-2-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-6-(trifluoromethyl)pyridazin-3-amine;N-[4-ethylsulfonyl-2-(1-methylimidazol-4-yl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine;4-ethylsulfonyl-2-(1-methylimidazol-4-yl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]aniline is sourced from PubChem (CID 160558480), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).